5C56.31ICD-11 MMS 2026-01
Mucopolysaccharidosis type 2
Description
Mucopolysaccharidosis type 2 (MPS 2) is a lysosomal storage disease belonging to the group of mucopolysaccharidoses. The clinical picture ranges from severe (the most frequent form) with early psychomotor regression, facial dysmorphism (macroglossia, constantly opened mouth, coarse features), hepatosplenomegaly, limited joint motion, carpal tunnel syndrome, dysostosis multiplex, small size, behavioural disorders and psychomotor regression leading to intellectual deficit, deafness, cardiac and respiratory disorders, and cutaneous signs, to mild (normal intelligence, milder dysmorphism and dysostoses).
Index terms
- Mucopolysaccharidosis type 2
- Hunter syndrome
- Iduronate 2-sulfatase deficiency
Show allHide
- MPS2 - [mucopolysaccharidosis 2]
- iduronate 2-sulphatase deficiency
- iduronate sulfatase deficiency
- iduronate sulphatase deficiency
- sulfo-iduronate sulfatase deficiency
- sulfoiduronidate sulfatase deficiency
- sulpho-iduronate sulphatase deficiency
- sulphoiduronidate sulphatase deficiency
- Mucopolysaccharidosis type 2A
- Hunter syndrome type A
- Iduronate 2-sulfatase deficiency type A
- Mucopolysaccharidosis type 2, severe form
- Mucopolysaccharidosis type 2B
- Hunter syndrome type B
- Iduronate 2-sulfatase deficiency type B
- Mucopolysaccharidosis type 2, attenuated form
- Mucopolysaccharidosis type 2, mild form
Inclusions
- Hunter syndrome
Exclusions from above levels
5C51.3– Glycogen storage disease due to LAMP-2 deficiency- http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
3A10.Z– Hereditary haemolytic anaemia due to enzyme deficiency
Show allHide
5A71.01– Congenital adrenal hyperplasia5A81.1– 5-alpha-reductase deficiencyLD28.01– Marfan syndromeLD28.1– Ehlers-Danlos syndromeLD2A.4– androgen resistance syndrome18– Pregnancy, childbirth or the puerperium- http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn
Sibling codes
Foundation entity
Mucopolysaccharidosis type 2 – http://id.who.int/icd/entity/1056274204
Part of: 5C56.3: Mucopolysaccharidosis › 5C56: Lysosomal diseases › 05: Endocrine, nutritional or metabolic diseases